Literature DB >> 25073787

The ageing males' symptoms scale for Chinese men: reliability,validation and applicability of the Chinese version.

X-b Kong1, H-t Guan, H-g Li, Y Zhou, C-l Xiong.   

Abstract

In this study, the ageing males' symptoms (AMS) scale was translated into Chinese following methodological recommendations for linguistic and cultural adaptation. This study aimed to confirm the reliability, validation and applicability of the simplified Chinese version of the scale (CN-AMS) in older Chinese men, a free health screening for men older than 40 years was conducted. All participants completed a health questionnaire, which consisted of personal health information, AMS scale, the generic quality of life (QoL) instrument SF36 and the Beck Depression Inventory (BDI). The fasting blood samples of participants were collected on the day of completing the health questionnaire. Serum total testosterone (TT), albumin and sex hormone-binding globulin levels were measured and the level of free testosterone was calculated (calculated free testosterone, CFT). A total of 244 men (mean age: 52 ± 7.3 years, range: 40-79 years) were involved in the investigation and provided informed consent before their participation. The reliability of CN-AMS was analysed as internal consistency reliability (Cronbach's alpha was 0.91) as well as a 4-week-interval test-retest stability (Pearson's correlation was 0.83) and found to be good. The validation of CN-AMS was analysed as the internal structure analysis (Pearson's correlation between total score and each item score r = 0.48-0.75), total-domain-correlation (among the three domains r = 0.47-0.68, p < 0.01; domains with the total score r = 0.81-0.88, p < 0.01), and cross-validation with other scales (with SF36 r = -0.59, p < 0.01; with BDI r = 0.50, p < 0.01). Androgen deficiency (AD) was defined as the presence of three sexual symptoms (decreased frequency of morning erections, sexual thoughts and erectile dysfunction) in combination with TT < 11 nmol/L and CFT < 220 pmol/L, and the sensitivity and specificity for CN-AMS was 68.8 and 6.8% respectively. The CN-AMS had sufficient sensitivity in screening AD of older men, but the low specificity made it unsuitable to be adopted as the diagnostic criteria. The scanning capability of AMS scale for AD has the downward trend with ageing and a hypothesis is proposed to give a possible reason for the new finding.
© 2014 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  AMS; ageing male; androgen deficiency; reliability; validation

Mesh:

Substances:

Year:  2014        PMID: 25073787     DOI: 10.1111/j.2047-2927.2013.00145.x

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  5 in total

1.  A Chinese Cross-Sectional Study on Symptoms in Aging Males: Prevalence and Associated Factors.

Authors:  Hongjun Li; Xinyu Zhang; Haibo Wang; Bin Yang; Ni Li; Zhigang Ji
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

2.  Decreased testosterone secretion index and free testosterone level with multiple symptoms for late-onset hypogonadism identification: a nationwide multicenter study with 5980 aging males in China.

Authors:  Honggang Li; Yiqun Gu; Xuejun Shang; Yuanzhong Zhou; Huiping Zhang; Liandong Zuo; Guangan Mei; Wei Xia; Huangtao Guan; Wenpei Xiang; Shanjie Zhou; Changchun Wan; Baojin Hao; Xubo Shen; Linguo Tang; Weixiong Wu; Ying Qi; Na Yu; Xiangbin Kong; Yaoping Chen; Yihong Yang; Xingrong Qing; Chengliang Xiong
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

3.  Associations between smoking, sex hormone levels and late-onset hypogonadism in men differ depending on age.

Authors:  Qian Liu; Xiangchi Peng; Yiqun Gu; Xuejun Shang; Yuanzhong Zhou; Huiping Zhang; Liandong Zuo; Guangan Mei; Chengliang Xiong; Honggang Li; Xiangbin Kong
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

4.  The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism.

Authors:  Yao-Ping Chen; Ju Wang; Kai Zhao; Xue-Jun Shang; Hui-Qin Wu; Xing-Rong Qing; Fang Fang; Yan Zhang; Jin Shang; Hong-Gang Li; Hui-Ping Zhang; Huang-Tao Guan; Yuan-Zhong Zhou; Yi-Qun Gu; Wei-Xiong Wu; Cheng-Liang Xiong
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

5.  Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial.

Authors:  Xi Wang; Suyuan Wang; Chenghui Zhang; Lingyu Zhong; Lilach Lerman; Amir Lerman; Yanhong Guo; Yunhong Wu; Francisco Lopez-Jimenez
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.